Cargando…

Stathmin dynamics modulate the activity of eribulin in breast cancer cells

Stathmin, a phosphoprotein that modulates microtubule dynamics, is highly expressed in breast cancer cells. Eribulin, a microtubule‐depolymerizing agent, is used to treat patients with advanced breast cancer. However, the detailed mechanisms underlying the action of eribulin during microtubule catas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshie, Mikihiro, Ishida, Akari, Ohashi, Haruka, Nakachi, Nami, Azumi, Mana, Tamura, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236080/ https://www.ncbi.nlm.nih.gov/pubmed/34176226 http://dx.doi.org/10.1002/prp2.786

Ejemplares similares

Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma
por: Tamura, Kazuhiro, et al.
Publicado: (2013)

Small GTP‐binding protein Rap1 mediates EGF and HB‐EGF signaling and modulates EGF receptor expression in HTR‐8/SVneo extravillous trophoblast cells
por: Yoshie, Mikihiro, et al.
Publicado: (2023)

PGRMC1 Regulates Cellular Senescence via Modulating FOXO1 Expression in Decidualizing Endometrial Stromal Cells
por: Tsuru, Atsuya, et al.
Publicado: (2022)

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)

Toll-like receptor signaling pathway triggered by inhibition of serpin A1 stimulates production of inflammatory cytokines by endometrial stromal cells
por: Kusama, Kazuya, et al.
Publicado: (2022)

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
por: Niwa, Yuki, et al.
Publicado: (2023)

Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
por: Yadav, Preeti, et al.
Publicado: (2016)

Overexpression of the stathmin gene in a subset of human breast cancer.
por: Bièche, I., et al.
Publicado: (1998)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin
por: Lee, Suee, et al.
Publicado: (2015)

Stathmin Potentiates Vinflunine and Inhibits Paclitaxel Activity
por: Malesinski, Soazig, et al.
Publicado: (2015)

Serum microRNA-based prediction of responsiveness to eribulin in metastatic breast cancer
por: Satomi-Tsushita, Natsuko, et al.
Publicado: (2019)

Inhibitory effect of insulin-like growth factor-binding protein-7 (IGFBP7) on in vitro angiogenesis of vascular endothelial cells in the rat corpus luteum
por: TAMURA, Kazuhiro, et al.
Publicado: (2014)

Eribulin in Cancer Treatment
por: Swami, Umang, et al.
Publicado: (2015)

Eribulin for Advanced Breast Cancer: A Drug Evaluation
por: Shablak, Alaaeldin
Publicado: (2013)

Case Studies in the Management of Metastatic Breast Cancer with Eribulin
por: Wilks, Sharon, et al.
Publicado: (2015)

Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice
por: Tanaka, Toshihiro, et al.
Publicado: (2017)

A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer
por: Liu, B., et al.
Publicado: (2023)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
por: Owusu-Brackett, Nicci, et al.
Publicado: (2019)

Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups
por: Askeland, Cecilie, et al.
Publicado: (2020)

Stathmin Is Dispensable for Tumor Onset in Mice
por: D’Andrea, Sara, et al.
Publicado: (2012)

Stathmin 1 in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2014)

Stathmin drives virus-induced metastasis
por: Whitehouse, Adrian, et al.
Publicado: (2015)

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours
por: Curmi, P A, et al.
Publicado: (2000)

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
por: Garrone, Ornella, et al.
Publicado: (2016)

Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
por: Ng, Dominic Chi Hiung, et al.
Publicado: (2006)

Eribulin drug review
por: Shetty, Nishitha, et al.
Publicado: (2014)

Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors
por: Brattsand, G
Publicado: (2000)

MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1
por: Wang, Rui, et al.
Publicado: (2012)

Stathmin 1 expression in plasma cell neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2017)

Molecular Evolution and Characterization of Fish Stathmin Genes
por: Cao, Jun, et al.
Publicado: (2020)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2014)

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer
por: Sonego, Maura, et al.
Publicado: (2013)

Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research Findings
por: Kok, Victor C.
Publicado: (2015)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
por: Doherty, Mark K, et al.
Publicado: (2015)

Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
por: Goto, Wataru, et al.
Publicado: (2020)

The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy
por: Xie, Zhen, et al.
Publicado: (2022)

Regulatory Action of Calcium Ion on Cyclic AMP-Enhanced Expression of Implantation-Related Factors in Human Endometrial Cells
por: Kusama, Kazuya, et al.
Publicado: (2015)

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
por: Ohtani, Shoichiro, et al.
Publicado: (2018)

Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
por: Mittal, Sonam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6mg915k127g8g3ik04ncdqlvtq